Saturday, 1 January 2022

NEW PATENTS, RELATED TO COVID 19

 


NEW PATENTS

WO/2021/258625ANTI-SAR-COV-2 (COVID-19) FULLY HUMANIZED MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES


WO/2021/260164THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONS

IN2CURE AB


WO/2021/211332METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-Β-CORONAVIRUS ANTIBODY IN A SAMPLE

ABBOTT LABORATORIES


4  WO/2021/262744KITS AND METHODS FOR ISOTHERMALLY AMPLIFYING RIBONUCLEIC ACID OF SEVERE ACUTE RESPIRATORY VIRUS COV2

UNIVERSITY OF WASHINGTON


WO/2021/262894METHODS FOR DIAGNOSING RESPIRATORY PATHOGENS AND PREDICTING COVID-19 RELATED OUTCOMES

THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE




////////////////

No comments:

Post a Comment